Prospective registry study investigating medical care in hematooncologic patients with venous thromboembolism in Berlin

Prospective registry study investigating medical care in hematooncologic patients with venous thromboembolism in Berlin - GECAT – German Evaluation of Cancer associated Thrombosis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00008196

Enrollment

300

Registered

2015-05-18

Start date

2015-05-10

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I80.9 C00-C75 I80.0

Interventions

Group 1: About 300 patients with new diagnosis of venous thrombembolism who recieve inpatient or outpatient treatment in the hospitals of charite Berlin or Vivantes GmbH Berlin shall be included

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with malignant disease of any kind and newly diagnosed venous thromboembolism who received inpatient or outpatient treatment in the hospitals of Vivantes/Charite. The malignant disease should have been diagnosed or have required treatment during the past two years.Patients with venous thromboembolism in whom malignant disease is diagnosed for the first time, in the course of diagnostic procedures due to venous thrombembolism

Exclusion criteria

Exclusion criteria: Patients suffering venous thromboembolism but not malignant disease will be registered only once by with reduced baseline documentation. There will be no follow up. They will not take part in follow-up-investigation.

Design outcomes

Primary

Measure	Time frame
Primary aim in the context of health care research is the documentation of the actual clinical practice of the treatment of these patients. By means of this registry study it will be possible for the first time to collect data on the patients’ medical history/career and medical pathways.	—

Secondary

Measure	Time frame
not relevant	—

Countries

Germany

Contacts

Public ContactRobert Klamroth

Vivantes Klinikum im FriedrichshainKlinik für Innere Medizin/Angiologie , Funktionsbereich Hämostaseologie

robert.klamroth@vivantes.de030/130231575

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026